Compared to the control group, the PRMT6 inhibitor suppressed tumor growth in vivo, and the boundary between tumor tissue and surrounding normal brain tissue in the PRMT6 inhibitor group was relatively clear (Fig. 8H-J). Here, PRMT6 is linked to neoplasm.